Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11243988.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Primary pulmonary hypertension (PPH) associated with pregnancy carries a high maternal mortality rate. Short-term epoprostenol infusion has been demonstrated to improve the hemodynamic profile in patients with PPH. We report a successful maternal-fetal outcome with epoprostenol therapy during pregnancy, cesarean section, and postpartum in a patient with PPH. Epoprostenol therapy did not produce any physical or developmental abnormalities in the fetus. A favorable maternal-fetal outcome may occur with a multidisciplinary approach.
Medical subject headings
- Antihypertensive Agents
- Epoprostenol
- Hypertension, Pulmonary
- Pregnancy Complications, Cardiovascular